参麦注射液和多巴酚丁胺对肺心病合并急性心衰的效果

Effect of Shenmai Injection Combined With Dobutamine on Patients With Pulmonary Heart Disease Combined With Acute Heart Failure

目的探讨联用参麦注射液和多巴酚丁胺对肺心病合并急性心衰的患者进行治疗的效果。方法对象共48例均为本院2016年9月—2017年12月所接收的肺心病合并急性心衰的患者,随机分为两组,对照组患者采用常规药物治疗,治疗组患者则是在常规治疗的基础上再联用参麦注射液和多巴酚丁胺进行治疗,对比两组治疗效果。结果患者在接受治疗后,其疾病临床症状出现了不同程度的改善,治疗组总有效率为91.67%,对照组为70.83%,治疗组与对照组差异有统计学意义(P<0.05)。结论在肺心病合并急性心衰疾病的临床治疗工作中,联用参麦注射液和多巴酚丁胺这一治疗方法是具有较高应用价值。

Objective To investigate the effect of combined Shenmai injection and dobutamine on patients with pulmonary heart disease combined with acute heart failure.Methods A total of 48 patients with pulmonary heart disease complicated with acute heart failure received in our hospital from September 2016 to December 2017 were randomly divided into two groups.The patients in the control group were treated with conventional medicine,and the patients in the treatment group were treated with Shenmai injection and dobutamine on the basis of routine treatment,and the effect of the two groups was compared.Results After treatment,the clinical symptoms of the patients improved to some extent.The effective rate of the treatment group was 91.67%,which was 70.83%in the control group.There was a significant difference between the treatment group and the control group(P<0.05).Conclusion The combination of Shenmai injection and dobutamine in the treatment of pulmonary heart disease with acute heart failure is of high application value.